Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9707)
All Articles published online
|
Publishing Process of This Article
|
Dec 10, 2017 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Said A, Ghufran A. Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma. World J Clin Oncol 2017; 8(6): 429-436 [PMID: 29291167 DOI: 10.5306/wjco.v8.i6.429] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v8/i6/429.htm |
| Number | Citing Articles |
| 1 |
Shih‐Wei Lai. Risk factors for hepatocellular carcinoma. Cancer 2019; 125(3): 482 doi: 10.1002/cncr.31802
|
| 2 |
Anne Sophie Schou, Jonas Ellegaard Nielsen, Anders Askeland, Malene Møller Jørgensen. . Advances in Clinical Chemistry 2020; 99: 1 doi: 10.1016/bs.acc.2020.02.011
|
| 3 |
Stephanie Chen, Samantha Chao, Monica Konerman, Wei Zhang, Huiying Rao, Elizabeth Wu, Andy Lin, Lai Wei, Anna S. Lok. Survey of Nonalcoholic Fatty Liver Disease Knowledge, Nutrition, and Physical Activity Patterns Among the General Public in Beijing, China. Digestive Diseases and Sciences 2019; 64(12): 3480 doi: 10.1007/s10620-019-05709-0
|
| 4 |
Naga Swetha Samji, Rajanshu Verma, Krishna Chaitanya Keri, Ashwani K. Singal, Aijaz Ahmed, Mary Rinella, David Bernstein, Manal F. Abdelmalek, Sanjaya K. Satapathy. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. Digestive Diseases and Sciences 2019; 64(12): 3413 doi: 10.1007/s10620-019-05716-1
|
| 5 |
Koichi Kato, Moto Fukai, Kanako C. Hatanaka, Akira Takasawa, Tomoyuki Aoyama, Takahiro Hayasaka, Yoshihiro Matsuno, Toshiya Kamiyama, Yutaka Hatanaka, Akinobu Taketomi. Versican Secreted by Cancer-Associated Fibroblasts is a Poor Prognostic Factor in Hepatocellular Carcinoma. Annals of Surgical Oncology 2022; 29(11): 7135 doi: 10.1245/s10434-022-11862-0
|
| 6 |
Arno Kornberg, Helmut Friess. 18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819836205
|
| 7 |
Takahiro Kodama, Jing Yi, Justin Y. Newberg, Jean C. Tien, Hao Wu, Milton J. Finegold, Michiko Kodama, Zhubo Wei, Takeshi Tamura, Tetsuo Takehara, Randy L. Johnson, Nancy A. Jenkins, Neal G. Copeland. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis. Proceedings of the National Academy of Sciences 2018; 115(44) doi: 10.1073/pnas.1808968115
|
| 8 |
Talhah Zubair, Timothy Yen, Gordon Gao. Solitary Extrahepatic Intramuscular Metastasis from Cryptogenic Hepatocellular Carcinoma. ACG Case Reports Journal 2018; 5(1): e64 doi: 10.14309/crj.2018.64
|
| 9 |
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. International Journal of Molecular Sciences 2021; 22(9): 4495 doi: 10.3390/ijms22094495
|
| 10 |
Chiao-Lin Hsu, Fu-Zong Wu, Kung-Hung Lin, Yu-Hsun Chen, Pin-Chieh Wu, Yan-Hua Chen, Chi-Shen Chen, Wen-Hwa Wang, Guang-Yuan Mar, Hsien-Chung Yu. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup. Clinical and Translational Gastroenterology 2019; 10(5): e00042 doi: 10.14309/ctg.0000000000000042
|
| 11 |
Han Lv, Mengyi Li, Yang Liu, Lei Zhao, Jing Sun, Di Cao, Na Zeng, Jia Liu, Yawen Liu, Shibo Bian, Peng Zhang, Zhenghan Yang, Zhongtao Zhang, Zhenchang Wang. The Clinical Value and Appropriateness Criteria of Upper Abdominal Magnetic Resonance Examinations in Patients Before and After Bariatric Surgery: a Study of 837 Images. Obesity Surgery 2020; 30(10): 3784 doi: 10.1007/s11695-020-04688-w
|
| 12 |
April D. Lake, Rhiannon N. Hardwick, Christopher P. Leamon, Philip S. Low, Nathan J. Cherrington. Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitis. Toxicology and Applied Pharmacology 2019; 368: 49 doi: 10.1016/j.taap.2019.02.009
|
| 13 |
Yasuyuki Shigematsu, Hiroaki Kanda, Gulanbar Amori, Yu Takahashi, Yutaka Takazawa, Kentaro Inamura. Nonalcoholic non-virus-related hepatocellular carcinoma arising from nonsteatotic liver. Medicine 2022; 101(5): e28746 doi: 10.1097/MD.0000000000028746
|
| 14 |
Tingting Shen, Yunfei Lu, Qin Zhang. High Squalene Epoxidase in Tumors Predicts Worse Survival in Patients With Hepatocellular Carcinoma: Integrated Bioinformatic Analysis on NAFLD and HCC. Cancer Control 2020; 27(1) doi: 10.1177/1073274820914663
|
| 15 |
Lijuan Liao, Deyu Duan, Yanfeng Liu, Liang Chen.
LHPP
inhibits hepatocellular carcinoma cell growth and metastasis
. Cell Cycle 2020; 19(14): 1846 doi: 10.1080/15384101.2020.1783472
|
| 16 |
Jie Huang, Meng Li, Wen-Jun Zhoua, Ze-Min Yao, Guang Ji, Li Zhang, Ming-Zhe Zhu. Integrated miRNA and mRNA analysis identified potential mechanisms and targets of qianggan extracts in preventing nonalcoholic steatohepatitis. World Journal of Traditional Chinese Medicine 2022; 8(1): 77 doi: 10.4103/2311-8571.335135
|
| 17 |
Ingo G. Steffen, Thomas Weissmann, Jan Holger Rothe, Dominik Geisel, Sascha S. Chopra, Johannes Kahn, Bernd Hamm, Timm Denecke. Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI?. Journal of Clinical Medicine 2020; 10(1): 98 doi: 10.3390/jcm10010098
|
| 18 |
Min Yao, Wenjie Zheng, Li Wang, Miao Fang, Zhizhen Dong, Dengfu Yao. Neoplasm. 2018; doi: 10.5772/intechopen.77400
|
| 19 |
Andrea G. Izquierdo, Marcos C. Carreira, María Amil, Carlos S. Mosteiro, Tomas Garcia‐Caballero, Alfredo Fernandez‐Quintela, María P. Portillo, Felipe F. Casanueva, Ana B. Crujeiras. An energy restriction‐based weight loss intervention is able to reverse the effects of obesity on the expression of liver tumor‐promoting genes. The FASEB Journal 2020; 34(2): 2312 doi: 10.1096/fj.201901147RR
|
| 20 |
D. Putzer, P. Schullian, E. Braunwarth, M. Fodor, F. Primavesi, B. Cardini, T. Resch, R. Oberhuber, M. Maglione, C. Margreiter, S. Schneeberger, S. Stättner, D. Öfner-Velano, W. Jaschke, R. J. Bale. Integrating interventional oncology in the treatment of liver tumors. European Surgery 2018; 50(3): 117 doi: 10.1007/s10353-018-0521-5
|
| 21 |
Christopher Brunson, Lucas Struycken, David Schaub, Jacob Ref, Daniel Goldberg, Jack Hannallah, Gregory Woodhead, Shamar Young. Comparative outcomes of trans-arterial radioembolization in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease-induced HCC: a retrospective analysis. Abdominal Radiology 2024; 49(8): 2714 doi: 10.1007/s00261-024-04295-8
|
| 22 |
Mikyung Kim, Yunmee Rho, Rhoeun Park, Jeeyoun Jung, Geum-Sook Hwang, Youn Kyoung Seo, Ji Hae Seo, Yoonseok Heo, Tae Kyung Ha, Eunyoung Ha. Duodenal-jejunal bypass maintains hepatic S-adenosylmethionine/S-homocysteine ratio in diet-induced obese rats. Surgery for Obesity and Related Diseases 2021; 17(7): 1359 doi: 10.1016/j.soard.2021.02.011
|
| 23 |
Rajesh Sharma. Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018. Japanese Journal of Clinical Oncology 2020; 50(12): 1370 doi: 10.1093/jjco/hyaa130
|
| 24 |
Jie Huang, Meng Li, Wen-Jun Zhoua, Ze-Min Yao, Guang Ji, Li Zhang, Ming-Zhe Zhu. Integrated miRNA and mRNA Analysis Identified Potential Mechanisms and Targets of Qianggan Extracts in Preventing Nonalcoholic Steatohepatitis. World Journal of Traditional Chinese Medicine 2022; 8(1): 77 doi: 10.4103/wjtcm.wjtcm_48_21
|
| 25 |
Imaad Said, Hassan Ahad, Adnan Said. Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics. World Journal of Gastrointestinal Oncology 2022; 14(5): 947-958 doi: 10.4251/wjgo.v14.i5.947
|
| 26 |
|
| 27 |
Yanan Zhang, Chunguang Wang, Hongqin Xu, Peng Xiao, Yanhang Gao. Hepatocellular carcinoma in the noncirrhotic liver: a literature review. European Journal of Gastroenterology & Hepatology 2019; 31(7): 743 doi: 10.1097/MEG.0000000000001419
|
| 28 |
Bronwen Williams, Nurun Tania, Lynsey Corless. Non-alcoholic fatty liver disease (NAFLD): survey of awareness and understanding among professionals in secondary care. Gastrointestinal Nursing 2019; 17(Sup6): S22 doi: 10.12968/gasn.2019.17.Sup6.S22
|
| 29 |
Hui Xia, Chun Liu, Cheng-Chung Li, Maobin Fu, Shingo Takahashi, Kang-Quan Hu, Koichi Aizawa, Suganuma Hiroyuki, Guojun Wu, Liping Zhao, Xiang-Dong Wang. Dietary Tomato Powder Inhibits High-Fat Diet–Promoted Hepatocellular Carcinoma with Alteration of Gut Microbiota in Mice Lacking Carotenoid Cleavage Enzymes. Cancer Prevention Research 2018; 11(12): 797 doi: 10.1158/1940-6207.CAPR-18-0188
|
| 30 |
Serdar A. Gurses, Sunil Banskar, Cody Stewart, Bill Trimoski, Roman Dziarski, Dipika Gupta. Nod2 protects mice from inflammation and obesity-dependent liver cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77463-7
|
| 31 |
Zhaoming Liu, Zhen Li, Binghui Xu, Hao Yao, Shuangyu Qi, Jianxiong Tai. <p>Long Noncoding RNA PRR34-AS1 Aggravates the Progression of Hepatocellular Carcinoma by Adsorbing microRNA-498 and Thereby Upregulating FOXO3</p>. Cancer Management and Research 2020; : 10749 doi: 10.2147/CMAR.S263619
|
| 32 |
Ozlem Kutlu, Humeyra Nur Kaleli, Ebru Ozer. Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/8543763
|
| 33 |
Manzoor Ahmad Mir, Shariqa Aisha, Shazia Sofi. Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies. 2022; : 1 doi: 10.1016/B978-0-443-18696-7.00010-5
|
| 34 |
Shivani Krishnamurthy, David Gilot, Seong Beom Ahn, Vincent Lam, Joo-Shik Shin, Gilles Jackie Guillemin, Benjamin Heng. Involvement of Kynurenine Pathway in Hepatocellular Carcinoma. Cancers 2021; 13(20): 5180 doi: 10.3390/cancers13205180
|
| 35 |
Ramesh Kumar, Rajeev Nayan Priyadarshi, Utpal Anand. Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations. Journal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00051
|
| 36 |
Lei Cao, Hongwei Cheng, Qiuxia Jiang, Hui Li, Zhixian Wu. APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma. Aging 2020; 12(5): 4573 doi: 10.18632/aging.102913
|
| 37 |
Noor Atika Azit, Shahnorbanun Sahran, Leow Voon Meng, Manisekar Subramaniam, Suryati Mokhtar, Azmawati Mohammed Nawi, Yun-Wen Zheng. Risk factors of hepatocellular carcinoma in type 2 diabetes patients: A two-centre study in a developing country. PLOS ONE 2021; 16(12): e0260675 doi: 10.1371/journal.pone.0260675
|
| 38 |
Jeongeun Hyun, Muthana Al Abo, Rajesh Kumar Dutta, Seh Hoon Oh, Kun Xiang, Xiyou Zhou, Raquel Maeso-Díaz, Rebecca Caffrey, Arun J. Sanyal, Jennifer A. Freedman, Steven R. Patierno, Cynthia A. Moylan, Manal F. Abdelmalek, Anna Mae Diehl. Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease. Journal of Hepatology 2021; 75(3): 623 doi: 10.1016/j.jhep.2021.04.033
|
| 39 |
Geru Tao, Guangjie Zhang, Wei Chen, Chao Yang, Yazhuo Xue, Guohua Song, Shucun Qin. A randomized, placebo‐controlled clinical trial of hydrogen/oxygen inhalation for non‐alcoholic fatty liver disease. Journal of Cellular and Molecular Medicine 2022; 26(14): 4113 doi: 10.1111/jcmm.17456
|
| 40 |
Lu Huang, Wei Ding, Ming-Qiang Wang, Zheng-Gen Wang, Hong-Hui Chen, Wen Chen, Qiong Yang, Ting-Na Lu, Qing Yang, Ji-Man He. Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4. Journal of International Medical Research 2019; 47(10): 5239 doi: 10.1177/0300060519859750
|
| 41 |
Ebbe Billmann Thorgersen, Andreas Barratt‐Due, Håkon Haugaa, Morten Harboe, Søren Erik Pischke, Per H. Nilsson, Tom Eirik Mollnes. The Role of Complement in Liver Injury, Regeneration, and Transplantation. Hepatology 2019; 70(2): 725 doi: 10.1002/hep.30508
|
| 42 |
Timothy M.E. Davis, Kirsten E. Peters, S. A. Paul Chubb, Leon A. Adams, Gary P. Jeffrey, Wendy A. Davis. Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes Study. Journal of Clinical Medicine 2020; 9(11): 3409 doi: 10.3390/jcm9113409
|
| 43 |
Hyun Jin Song, Xinyi Jiang, Linda Henry, Mindie H. Nguyen, Haesuk Park. Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 2020; 76(6): 851 doi: 10.1007/s00228-020-02854-8
|
| 44 |
Xiaoyu Liu, Wenhui Ju, Chuanhong Huo, Shuhong Zhang, Xingang Wang, Kai Huang. Overweight and Obesity as Independent Factors for Increased Risk of Hepatocellular Cancer-Related Mortality: A Meta-Analysis. Journal of the American College of Nutrition 2021; 40(3): 287 doi: 10.1080/07315724.2020.1751007
|
| 45 |
Zobair M. Younossi, Linda Henry. Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma. JHEP Reports 2021; 3(4): 100305 doi: 10.1016/j.jhepr.2021.100305
|
| 46 |
Mélissa Léveillé, Jennifer L. Estall. Mitochondrial Dysfunction in the Transition from NASH to HCC. Metabolites 2019; 9(10): 233 doi: 10.3390/metabo9100233
|
| 47 |
Claudia Isabel García-Berumen, Omar Ortiz-Avila, Manuel Alejandro Vargas-Vargas, Bricia A. del Rosario-Tamayo, Clotilde Guajardo-López, Alfredo Saavedra-Molina, Alain Raimundo Rodríguez-Orozco, Christian Cortés-Rojo. The severity of rat liver injury by fructose and high fat depends on the degree of respiratory dysfunction and oxidative stress induced in mitochondria. Lipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1024-5
|
| 48 |
Rodrigo Valenzuela, Macarena Ortiz, María Catalina Hernández-Rodas, Francisca Echeverría, Luis Alberto Videla. Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease. Current Medicinal Chemistry 2020; 27(31): 5250 doi: 10.2174/0929867326666190410121716
|
| 49 |
Songsong Wu, Sheng Chen, Ning Lin, Jianchuan Yang. Long non‐coding RNA SUMO1P3 promotes hepatocellular carcinoma progression through activating Wnt/β‐catenin signalling pathway by targeting miR‐320a. Journal of Cellular and Molecular Medicine 2020; 24(5): 3108 doi: 10.1111/jcmm.14977
|
| 50 |
Victor de Avila, James M. Paik, Leyla de Avila, Linda Henry, Denise Mohess, Alva Roche-Green, Zobair M. Younossi. Hospice care utilisation among elderly patients who died with hepatocellular carcinoma in the United States. JHEP Reports 2021; 3(2): 100236 doi: 10.1016/j.jhepr.2021.100236
|
| 51 |
Utibe-Abasi S. Udoh, Pradeep Kumar Rajan, Yuto Nakafuku, Robert Finley, Juan Ramon Sanabria. Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022; 23(14): 7734 doi: 10.3390/ijms23147734
|
| 52 |
Pei-Chin Lin, Wan-Yi Hsu, Po-Yi Lee, Shih-Hsien Hsu, Shyh-Shin Chiou. Insights into Hepatocellular Carcinoma in Patients with Thalassemia: From Pathophysiology to Novel Therapies. International Journal of Molecular Sciences 2023; 24(16): 12654 doi: 10.3390/ijms241612654
|
| 53 |
Flavio A. Cadegiani. Dietary Interventions in Liver Disease. 2019; : 39 doi: 10.1016/B978-0-12-814466-4.00004-5
|
| 54 |
V. V. Pavan Kedar Mukthinuthalapati, Vikash Sewram, Ntokozo Ndlovu, Stephen Kimani, Ashraf Omar Abdelaziz, Elizabeth Yu Chiao, Ghassan K. Abou-Alfa. Hepatocellular Carcinoma in Sub-Saharan Africa. JCO Global Oncology 2021; (7): 756 doi: 10.1200/GO.20.00425
|
| 55 |
Mami Takahashi, Mika Hori, Rikako Ishigamori, Michihiro Mutoh, Toshio Imai, Hitoshi Nakagama. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans. Cancer Science 2018; 109(10): 3013 doi: 10.1111/cas.13766
|
| 56 |
Jessica H. Hill, Claudia Solt, Michelle T. Foster. Obesity associated disease risk: the role of inherent differences and location of adipose depots. Hormone Molecular Biology and Clinical Investigation 2018; 33(2) doi: 10.1515/hmbci-2018-0012
|
| 57 |
Monika Pazgan-Simon, Michał Kukla, Jolanta Zuwała-Jagiełło, Aleksandra Derra, Martyna Bator, Tomasz Menżyk, Andrzej Lekstan, Ewa Grzebyk, Krzysztof Simon, Matias A. Avila. Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC). PLOS ONE 2020; 15(1): e0227459 doi: 10.1371/journal.pone.0227459
|
| 58 |
Meng Zhang, Yuan Yuan, Qing Wang, Xiaobo Li, Jiuzhang Men, Mingxin Lin. The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα. Bioscience Reports 2018; 38(6) doi: 10.1042/BSR20180644
|
| 59 |
Joe L. Rowles, Aiguo Han, Rita J. Miller, Jamie R. Kelly, Catherine C. Applegate, Matthew A. Wallig, William D. O’Brien, John W. Erdman. Low fat but not soy protein isolate was an effective intervention to reduce nonalcoholic fatty liver disease progression in C57BL/6J mice: monitored by a novel quantitative ultrasound (QUS) method. Nutrition Research 2019; 63: 95 doi: 10.1016/j.nutres.2018.12.003
|
| 60 |
Nermin Raafat, Tarik I. Zaher, Rasha L. Etewa, Khaled M. El-gerby, Noha A. Rezk. Heat shock protein-27 and MiR-17-5p are novel diagnostic and prognostic biomarkers for hepatocellular carcinoma in Egyptian patients. Gene Reports 2020; 21: 100822 doi: 10.1016/j.genrep.2020.100822
|
| 61 |
Yu-Shan Lee, Lee-Ching Hwang, Hsin-Yin Hsu, Meng-Ting Tsou. The Association Between Different Obesity Phenotypes and Liver Fibrosis Scores in Elderly Individuals with Fatty Liver in Taiwan. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 1473 doi: 10.2147/DMSO.S302207
|
| 62 |
Margarita N. German, Megan K. Lutz, Perry J. Pickhardt, Richard J. Bruce, Adnan Said. Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 2020; 54(8): 733 doi: 10.1097/MCG.0000000000001260
|
| 63 |
Tomoki Abe, Daisaku Yamada, Kei Asukai, Shinichiro Hasegawa, Akira Tomokuni, Hiroshi Wada, Wataru Fujii, Kenji Ikezawa, Nobuyasu Fukutake, Kazuyoshi Ohkawa, Naoki Shinno, Hisashi Hara, Yoshitomo Yanagimoto, Yusuke Takahashi, Keijiro Sugimura, Kazuyoshi Yamamoto, Hajime Ushigome, Naotsugu Haraguchi, Junichi Nishimura, Masayoshi Yasui, Takeshi Omori, Hiroshi Miyata, Masayuki Ohue, Masahiko Yano, Masato Sakon, Hidenori Takahashi. Decreased CT-number in the pancreatic parenchyma is a reliable imaging biomarker of the presence of malignancies in patients with high-risk intraductal papillary mucinous neoplasm. Pancreatology 2020; 20(3): 442 doi: 10.1016/j.pan.2020.02.014
|
| 64 |
Michael Kram. Galectin-3 inhibition as a potential therapeutic target in non-alcoholic steatohepatitis liver fibrosis. World Journal of Hepatology 2023; 15(2): 201-207 doi: 10.4254/wjh.v15.i2.201
|